Avedis Donabedian Research Excellence Award
Deborah Marshall, PhD, MSHA
Canada Research Chair, Health Services and Systems Research; Associate Professor, Department of Community Health Sciences, Faculty of Medicine, University of Calgary; Director, Health Technology Assessment, Alberta Bone and Joint Health Institute, Calgary, AB, Canada
The ISPOR Avedis Donabedian Outcomes Research Lifetime Achievement Award is established in honor of the late Avedis Donabedian MD, MPH to acknowledge those individuals who have made a major contribution to the improvement of health outcomes. Dr. Donabedian was a renowned faculty member of the University of Michigan School of Public Health, multiple Award-winner, author of eight books, more than 50 peer-reviewed articles, and countless lectures on the subject of outcomes research. He dedicated his life to improving the quality of health care and health care systems, and directed such research towards health outcomes as the measure of quality. He has been called the "Father of Outcomes Research".
The ISPOR Avedis Donabedian Outcomes Research Lifetime Achievement Award is international in scope and stature. The Award recognizes an individual's outstanding, life-long achievement in the area of improving health outcomes. It will be presented on a frequency determined by the ISPOR Lifetime Achievement Awards Committee, but not more than one time per year.
The Award is open to any person who through his or her life's endeavors has demonstrated a significant and lasting contribution towards better health outcomes in a population or sub-population, as defined by the Lifetime Achievement Awards Committee. The Award is targeted towards demonstrated value delivered in health outcomes, rather than purely academic achievement. Therefore, nominees will be expected to have demonstrated tangible and persistent contributions that led towards improved health outcomes in an dentifiable group of individuals. Academicians, industry professionals, economists, researchers and others who meet these criteria are eligible, including ISPOR members. Self-nominations are discouraged. Deceased persons are not eligible for the Award. However, should the recipient die prior to receiving the Award, it may be presented posthumously.
A candidate may only be nominated for one major ISPOR award in a year.
The Call for Nominations will be advertised in the Value & Outcomes Spotlight, on the ISPOR website, and any other appropriate journal/newsletter. Anyone who meets the criteria above may be nominated. Nominations may be made by any ISPOR member. Members may nominate more than one person; however a completed letter of recommendation must accompany each nomination. Nominators are responsible for ensuring that all necessary documentation is forwarded with their submission.
The Lifetime Achievement Awards Committee selects the recipient by reviewing the materials submitted for each nominee and determining the overall impact of his or her contributions towards improving health outcomes. The Donabedian Award is targeted towards demonstrated value delivered in health outcomes rather than purely academic achievement. The Committee will then recommend the recipient of the Award to the Board of Directors.
Nature of the Award:
The Award will be announced and presented to the chosen individual at either the ISPOR International Meeting or the ISPOR European Congress, as appropriate. The Award recipient will receive a complimentary registration and travel expenses to the next ISPOR Annual International Meeting or ISPOR European Congress that convenes immediately following the Award selection process. The recipient will also have the opportunity to address the general assembly at either of these meetings, or alternatively address the membership of ISPOR through a commentary in Value in Health.
Nominations for the Avedis Donabedian Outcomes Research Lifetime Achievement Award require a letter of support for the nominee and a current edition of the nominee's CV, and sent to: email@example.com.
F. Reed Johnson, PhD
Professor, Duke School of Medicine
Duke Clinical Research Institute, Duke University
Durham, NC, USA
F. Reed Johnson, PhD, has more than 40 years of academic and research experience in health and environmental economics. He has served on the faculties of universities in the United States, Canada, and Sweden, as Distinguished Fellow at Research Triangle Institute, and currently as Professor in the Departments of Population Health Sciences and Medicine, Duke School of Medicine, as well as appointments in the Center for Health Measurement and the Duke Clinical Research Institute. As a staff member in the US Environmental Protection Agency’s environmental economics research program during the 1980s, Dr. Johnson helped pioneer development of nonmarket valuation techniques. These methods are now widely used in federally mandated regulatory impact studies, for estimating the value of improved health outcomes, and for quantifying patients’ tolerance for treatment-related risks. Dr. Johnson has over 140 publications in books and peer-reviewed journals. His research has been published in numerous medical, health-economics, environmental-economics, and general-economics journals. He has coauthored a book on techniques for using existing environmental and health value estimates for policy analysis. He led the first FDAsponsored study to quantify patients’ willingness to accept benefit-risk tradeoffs for new health technologies. The study was used to inform recent FDA guidance on submitting patient-preference data to support regulatory reviews of medical devices. His current research involves quantifying patients’ willingness to accept sideeffect risks in return for therapeutic benefits and estimating general time equivalences among health states. He is a founding member of the International Academy of Health Preference Research. He currently serves on the editorial board for The Patient, the Science Advisory Board for the U.S. Environmental Protection Agency, and the ISPOR Health Science Policy Council.
Institute of Health Sciences, University of Leeds
Paul Kind, is professor of Health Outcome Measurement at the University of Leeds, UK, and the lead international scientist at the Centre for Health Economics, Management, and Policy at the National Research University Higher School of Economics, St Petersburg, Russia. For more than 40 years, Paul has worked on research regarding the valuation of health benefits for use in clinical and economic evaluation. In addition to his academic work, Paul has acted as a consultant to government and international agencies, and has provided technical support to leading pharmaceutical companies. A founder member of the EuroQoL Group, Paul has only recently stepped down from its leadership team, having served variously as its president and chair of its Scientific Executive. Paul first presented at an ISPOR meeting in 1997 and went on to lead its Quality of Life SIG before subsequently serving as an elected member on the Board of Directors. Collaboration with research colleagues in Latin America and Russia provides Paul with a continuing stream of new projects and challenges. He is completing a long-standing assignment documenting the history of the value and valuation of health.
Pennifer Erickson, PhD
Co-founder and scientific director of The On-Line Guide to Quality-of-Life Assessment (OLGA)
Dr. Erickson. Pennifer Erickson serves as co-founder and scientific director of The On-Line Guide to Quality-of-Life Assessment (OLGA), an organization that identifies health-related quality-of-life assessments used in clinical practice, clinical trials, and evaluation studies. Before starting OLGA, she developed the Clearinghouse on Health Indexes and its principal output, a quarterly annotated bibliography at the National Center for Health Statistics (NCHS).
While at NCHS, Dr. Erickson led the development of the Health and Activity Limitation Index (HALex) and the Healthy People 2000 Years of Healthy Life, both of which were used to monitor the health of the US population from 1990 through 2000 as part of the US Public Health Service’s Healthy People initiative.
In addition, she was one of the first to map data collected using health status questionnaires into utility-based health-related quality-of-life scores. This approach was used to create analogs of the quality of well-being and the health utility index using data collected in national health surveys.
After leaving NCHS, Dr. Erickson joined the faculty at Penn State University’s Hershey Medical College.
Professor Anthony John (Tony) Culyer, CBE, BA, Hon DEcon, Hon FRCP, FRSA, FMedSci
Emeritus Professor of Economics, University of York, Heslington, York, UK
Tony Culyer is Emeritus Professor of economics at York (England); Chair, NICE International Advisory Group, London, England; Senior Fellow at the Institute of Health Policy, Management and Evaluation, University of Toronto; Adjunct Scientist, Institute for Work and Health, Toronto; and Distinguished Visiting Scholar, University of the Witwatersrand, South Africa.
He was the founding Organiser of the Health Economists' Study Group. For 33 years he was the founding co-editor, with Joe Newhouse, of Journal of Health Economics. He was founding Vice Chair of the National Institute for Health and Care Excellence (NICE). For many years he was chair of the Office of Health Economics in London. He is Editor-in-Chief of the on-line Encyclopaedia of Health Economics. He was responsible for the 1994 report that led to the redesign of the NHS's R&D system. For many years he was chair of the Department of Economics & Related Studies at York and, for six of them, was also deputy vice-chancellor.
He has published widely, mostly in health economics. The third edition of his The Dictionary of Health Economics (Edward Elgar) came out in 2014. A collection of his non-technical essays called The Humble Economist is available on-line free of charge.
Bengt Jönsson, PhD
Professor Emeritus of Health Economics, Stockholm School of Economics (SSE), Sweden
Bengt Jönsson, PhD, is Professor Emeritus of Health Economics at the Stockholm School of Economics (SSE), Sweden. Before joining the SSE in 1990, he was professor at Linköping University, Department of Health and Society, 1982-1990. He was director of the Swedish Institute for Health Economics (IHE) in Lund from 1979 to 1982. He is now chair of IHE scientific advisory board. He is also a member of the European Academy of Cancer Sciences, and vice chair of the EU Expert Panel on effective ways of Investing in health. Professor Jönsson has been a member of the Karolinska University Hospital Board, of the National Social Insurance Board in Sweden, and of SBU (The Swedish Council on Technology Assessment in Health Care), Scientific Advisory Board 1988-2004. Professor Jönsson is a member of the editorial boards of several journals, including the Journal of Cancer Policy, European Journal of Health Economics, and International Journal of Technology Assessment in Health Care. He is past president of Swedish Health Economics Association (SHEA), and the International Health Economists Association (iHEA).
Josephine Mauskopf, PhD, MHA
Vice President, Health Economics at RTI‑HS
Donald Patrick, PhD, MSPH
Director, University of Washington, Seattle, WA, USA
Sir Michael Rawlins, MD, FMedSci
Chairman, National Institute of Health & Clinical Excellence (NICE), London, UK
Milton C. Weinstein, Ph.D.
Professor Health Policy & Management
Harvard School of Public Health, Boston, MA
He is best known for his research on cost-effectiveness of medical practices and for developing methods of economic evaluation and decision analysis in health care. He is a co-developer of the CEPAC (Cost-Effectiveness of Preventing AIDS Complications) computer simulation model, and has conducted studies on prevention and treatment of HIV infections. He is the co-developer of the Coronary Heart Disease Policy Model, which has been used to evaluate the cost-effectiveness of cardiovascular prevention and treatment. He is an author of four books: Decision Making in Health and Medicine: Integrating Evidence and Values; Cost-Effectiveness in Health and Medicine, the report of the Panel of Cost Effectiveness in Health and Medicine; Clinical Decision Analysis; and Hypertension: A Policy Perspective. He has also published more than 200 papers in peer-reviewed medical, public health, and economics journals.
He consults with industry and government and is a Principal Consultant with i3 Innovus. He is an elected member of the Institute of Medicine of the National Academy of Sciences, and a recipient of the Award for Career Achievement from the Society for Medical Decision Making. Dr. Weinstein received his A.B. and A.M. in Applied Mathematics (1970), his M.P.P. (1972), and his Ph.D. in Public Policy (1973) from Harvard University.
Dr. Luce is a consultant to numerous government agencies as well as pharmaceutical and device firms worldwide, a member or chair of socioeconomic and public health policy advisory boards for several leading pharmaceutical companies, and recently was a member of the Medicare Evidence Development & Coverage Advisory Committee (MedCAC). He holds academic appoints as Senior Scholar with the Department of Health Policy, Jefferson Medical College and Adjunct Senior Fellow of the Leonard Davis Institute, University of Pennsylvania. In addition, Dr. Luce is on the editorial boards of several leading health journals, including Value in Health and the American Journal of Managed Care. He has authored more than eighty scientific publications, including three textbooks on technology assessment, health policy, and cost-effectiveness analysis. Dr. Luce founded and chairs the Bayesian Initiative in Health Economics and Outcomes Research. He is a Past President of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and is a Lieutenant Colonel (Retired), Medical Service Corps, US Army Reserves. Dr. Luce's undergraduate and masters training were at the Universities of Vermont and Massachusetts at Amherst. He received his Doctorate from the School of Public Health at the University of California at Los Angeles (UCLA).
As a practitioner, the results of studies conducted by Dr. Torrance have laid a foundation for evidence-based medicine and health policy and contributed to a more efficient allocation of resources in healthcare. Dr. Torrance is truly one of the pioneers in our field.
His main research interest is in the economic evaluation of health care programmes and he has undertaken a wide range of empirical studies. In addition, he has written numerous ethodological papers and co-authored one of the main textbooks in the field.
In addition to his academic work, he has acted as consultant to the WHO and participated in numerous projects for the European Union. He is also Vice-President (European Operations) for Innovus, a contract research organization. He has served on numerous government committees in the UK, including the Medicines Commission and the National Institute for Clinical Excellence (NICE) Guidelines Advisory Committee.
Prior to founding QualityMetric, Dr. Ware served for 12 years as Senior Scientist, The Health Institute, Tufts New England Medical Center in Boston, and served as the Principal Investigator for the Medical Outcomes Study (MOS), where he developed the SF-36® Health Survey and other tools widely used in monitoring patient outcomes. Prior to moving to Boston in 1988, he was Senior Research Psychologist for 14 years at the RAND Corporation where he developed the health status and patient satisfaction measures used in the Health Insurance Experiment. His hundreds of publication credits include papers from the MOS, which received the Association for Health Service Research (ASHR) "Article of the Year" Award for 1993.
In addition to his election to the IOM, Dr. Ware's awards and honors include Pepperdine University's 25th Annual Dolores Award to the outstanding graduate in psychology and education, AHSR's 1994 "Distinguished Investigator" Award, the 1998 Novartis/Zitter Group "Outcomes Leadership Award" for his work in advancing the science of outcomes research, and in 1999, he was the individual recipient of the Ellwood Award presented by the Foundation for Accountability (FACCT), in recognition of his lifetime efforts and contribution to the creation "of a consumer-focused, accountable health care system".